Main Content

Publications 2026

de Pedro MÁ, Pulido M, Marchena AM, Álvarez V, González-Nuño FM, Szymański W, Pörschke J, Reinartz S, Graumann J, Pogge von Strandmann E, Sánchez-Margallo FM, Gómez-Serrano M and López E. Menstrual blood-derived mesenchymal stromal cell secretome modulates macrophage polarization in a preconditioning-dependent manner. Front. Cell Dev. Biol., 22 January 2026. doi: 10.3389/fcell.2025.1691010

Preußer C, Salander DJ, Szymanski W, Graumann J, Wang Y, Zhao K, Bartsch JW, Gómez-Serrano M, Bachurski D, Reinartz S, Pogge von Strandmann E. Isolation defines identity: Functional consequences of Extracellular vesicle purification strategies. Advanced Healthcare Materials, 2026; 0:e04684. doi: 10.1002/adhm.202504684

Pörschke J, Heidemann S, Nehring HP, Lluch A, Szymański W, Finkernagel F, Preußer C, Bhagwat AM, Stamm TJ, Sommerfeld L, Helmprobst F, Müller R, Reinartz S, Graumann J, Pogge von Strandmann E, Gómez-Serrano M. Tumor-associated macrophages display differential protein cargo sorting in extracellular vesicles associated with poor survival in ovarian cancer. Mol Med. 2026 Jan 30;32(1):16. doi: 10.1186/s10020-025-01416-x

von Wichert L, Stroh A, Witt M, Wanzel M, Mernberger M, Griewing S, Wündisch T, Pfitzner BM, Teply-Szymanski J, Litmeyer AS, Denkert C, Wagner U, Stiewe T, Gremke N. mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancer. Cell Death Dis. 2026 Feb 19;17(1):235. doi: 10.1038/s41419-026-08496-5.

Merle N, Bullwinkel I, Timofeev O, Elmshäuser S, Stiewe S. Secreted luciferases as a minimally invasive 3R-compliant tool for accurate monitoring of tumor burden. Nat Protoc . 2026 Aug;21(8):3580-3613. doi: 10.1038/s41596-025-01315-9.

Dreute J, Schmitz ML. iBiT: A vector system allowing stable genome integration and scalable expression of NanoLuc fusion proteins to monitor dynamic protein-protein interactions in intact cells. Plasmid. 2026 May 23:135:102772. doi: 10.1016/j.plasmid.2026.102772.

Alashkar Alhamwe B, Alhamdan F, Ponath V, Hoffmann N, Meena C, Fingernagel F, Garn H, Pauk K, Keber C, Denkert C, Reinartz S, Pogge von Strandmann E. Ascites reprograms innate lymphoid immune cells in ovarian cancer by promoting ILC2 enrichment and dysfunctional NK-cell states. J Immunother Cancer. 2026 Aug 26;14(8):e015396. doi: 10.1136/jitc-2026-015396.

Heidemann S, Finkernagel F, Steitz AM, Koennecke J, Werner F, Beutgen VM, Szymanski W, Graumann J, Teply-Szymanski J, Nist A, Stiewe T, Keber CU, Gremke N, Wagner U, Denkert C, Gómez-Serrano M, Pogge von Strandmann E, Müller R, Reinartz S. A pro-inflammatory metastasis-associated macrophage subset induces tumor-promoting mesothelial cell conversion in ovarian cancer via IL-1α secretion. Cell Death Dis. 2026 Sep 12;17(1):794. doi: 10.1038/s41419-026-09280-1.

Kersten MC, Witt M, Stiewe T, Gremke N, Taudte RV. 2-deoxy-d-ribose: A multifaceted player at the crossroads of cancer metabolism. Biomed Pharmacother. 2026 Sep:202:119800. doi: 10.1016/j.biopha.2026.119800.